Geisinger and Boehringer Ingelheim collaborate to create a predictive diabetes model
Geisinger and Boehringer Ingelheim announced a collaboration to develop a risk-prediction model for three critical health outcomes commonly associated with type 2 diabetes that have long-term impact and cost-of-care implications: cardiovascular death, kidney failure and hospitalization. September 25, 2017